Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to $5.0 million.

  • Aveanna Healthcare Holdings' Share-based Compensation rose 118.32% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year increase of 6840.03%. This contributed to the annual value of $17.5 million for FY2024, which is 3274.3% up from last year.
  • Aveanna Healthcare Holdings' Share-based Compensation amounted to $5.0 million in Q3 2025, which was up 118.32% from $5.2 million recorded in Q2 2025.
  • Over the past 5 years, Aveanna Healthcare Holdings' Share-based Compensation peaked at $12.2 million during Q1 2022, and registered a low of $712000.0 during Q2 2021.
  • For the 5-year period, Aveanna Healthcare Holdings' Share-based Compensation averaged around $4.7 million, with its median value being $4.8 million (2022).
  • The largest annual percentage gain for Aveanna Healthcare Holdings' Share-based Compensation in the last 5 years was 57626.4% (2022), contrasted with its biggest fall of 8542.74% (2022).
  • Aveanna Healthcare Holdings' Share-based Compensation (Quarter) stood at $712000.0 in 2021, then surged by 150.7% to $1.8 million in 2022, then surged by 68.85% to $3.0 million in 2023, then soared by 65.3% to $5.0 million in 2024, then fell by 0.44% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $5.2 million for Q2 2025, and $11.0 million during Q1 2025.